¥2,089.50
0.65% today
Tokyo, Dec 25, 07:15 am CET
ISIN
JP3435750009
Symbol
2413
Index

M3 Stock price

¥2,090.00
-492.50 19.07% 1M
+79.00 3.93% 6M
+693.00 49.61% YTD
+723.50 52.95% 1Y
-1,453.00 41.01% 3Y
-7,221.00 77.55% 5Y
+843.00 67.60% 10Y
+1,838.33 730.46% 20Y
Tokyo, Closing price Thu, Dec 25 2025
+14.00 0.67%
ISIN
JP3435750009
Symbol
2413
Index

New AI Insights on M3 Insights AI Insights on M3

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
¥1.4t
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
30.7 | 28.7
P/S
4.3 | 3.8
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
¥21.00
Yield 1Y | 5Y
1.0% | 0.3%
Growth 1Y | 5Y
10.5% | 24.6%
Payout 1Y | 3Y
31.5% | 24.1%
Increased
17 Years
Financials (TTM | estimate)
Revenue
¥331.0b | ¥366.0b
EBITDA
¥82.5b | ¥90.2b
EBIT
¥67.0b | ¥15.7b
Net Income
¥45.9b | -
Free Cash Flow
¥53.1b
Growth (TTM | estimate)
Revenue
33.5% | 28.5%
EBITDA
24.6% | 24.0%
EBIT
18.8% | -74.7%
Net Income
17.2% | -
Free Cash Flow
7.8%
Margin (TTM | estimate)
Gross
51.2%
EBITDA
24.9% | 24.7%
EBIT
20.3%
Net
13.9% | -
Free Cash Flow
16.1%
Financial Health
Equity Ratio
65.1%
Return on Equity
10.7%
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
¥67.6
FCF per Share
-
Short interest
-
Employees
12k
Rev per Employee
¥23.6m
Show more

Is M3 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

M3 Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a M3 forecast:

10x Buy
53%
9x Hold
47%

Analyst Opinions

19 Analysts have issued a M3 forecast:

Buy
53%
Hold
47%

Financial data from M3

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
330,966 330,966
34% 34%
100%
- Direct Costs 161,512 161,512
53% 53%
49%
169,454 169,454
19% 19%
51%
- Selling and Administrative Expenses 102,457 102,457
25% 25%
31%
- Research and Development Expense - -
-
-
82,546 82,546
25% 25%
25%
- Depreciation and Amortization 15,508 15,508
58% 58%
5%
EBIT (Operating Income) EBIT 67,038 67,038
19% 19%
20%
Net Profit 45,901 45,901
17% 17%
14%

In millions JPY.

Don't miss a Thing! We will send you all news about M3 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evidence Solutions segment includes clinical research support business, medical clinical trials management, and management support business. The Overseas segment offers marketing support and research services for medical-related firms in the United States, the United Kingdom, and South Korea. The Clinical Platform segment engages in the development, sale and support of electronic medical records. The Others segment offers information services for medical institutions and prescription drug advertising business. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Itaru Tanimura
Employees 12,100
Founded 2000
Website corporate.m3.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today